Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

BRENDA Home
show all | hide all No of entries

Information on EC 3.1.3.36 - phosphoinositide 5-phosphatase and Organism(s) Homo sapiens and UniProt Accession Q01968

for references in articles please use BRENDA:EC3.1.3.36
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
     3 Hydrolases
         3.1 Acting on ester bonds
             3.1.3 Phosphoric-monoester hydrolases
                3.1.3.36 phosphoinositide 5-phosphatase
IUBMB Comments
These enzymes can also remove the 5-phosphate from Ins(1,4,5)P3 and/or Ins(1,3,4,5)P4. They are a diverse family of enzymes, with differing abilities to catalyse two or more of the four reactions listed. They are thought to use inositol lipids rather than inositol phosphates as substrates in vivo. All of them can use either or both of PtdIns(4,5)P2 and PtdIns(3,4,5)P3 as substrates; this is the main property that distinguishes them from EC 3.1.3.56, inositol-polyphosphate 5-phosphatase.
Specify your search results
Select one or more organisms in this record: ?
This record set is specific for:
Homo sapiens
UNIPROT: Q01968
Show additional data
Do not include text mining results
Include (text mining) results
Include results (AMENDA + additional results, but less precise)
Word Map
The taxonomic range for the selected organisms is: Homo sapiens
The expected taxonomic range for this enzyme is: Eukaryota, Bacteria
Synonyms
ship2, ship1, ocrl1, synaptojanin, inpp5e, synj1, phosphoinositide phosphatase, inositol polyphosphate 5-phosphatase, inositol 5-phosphatase, ci-vsp, more
SYNONYM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
inositol polyphosphate 5-phosphatase
-
OCRL1a
OCRL1 exists as two slice isoforms that differ by a single exon encoding 8 amino acids. The longer protein, termed isoform a, is the only form in brain, while both isoforms are present in all other tissues
5-ptase
-
-
5PTase
-
-
-
-
DGKeta
-
-
diphosphoinositide phosphatase
-
-
-
-
inositol 1,4,5-trisphosphate 5-phosphatase
-
-
inositol polyphosphate 5-phosphatase
inositol polyphosphate 5-phosphatase 2
-
-
inositol triphosphate 5-phosphomonoesterase
-
-
-
-
INPP5E 5-phosphatase
-
IP5P
-
-
Lowe's oculocerebrorenal syndrome protein
-
-
-
-
OCRL phosphatase
-
-
OCRL protein
-
-
-
-
p150
-
-
-
-
phosphatase, triphosphoinositide
-
-
-
-
phosphatidyl 4,5-bisphosphate-specific phosphomonoesterase
-
-
-
-
phosphatidyl bisphosphate phosphatase
-
-
-
-
phosphatidyl-inositol 4,5-bisphosphate 5-phosphatase
-
-
-
-
phosphatidyl-myo-inositol-4,5-bisphosphate phosphatase
-
-
-
-
phosphatidyl-myo-inositol-4,5-bisphosphate phosphohydrolase
-
-
-
-
phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase
-
-
phosphatidylinositol 4,5-bisphosphate 5-phosphatase
-
-
phosphatidylinositol 4,5-bisphosphate phosphatase
-
-
-
-
phosphatidylinositol-4,5-bisphosphate 5-phosphatase
-
-
phosphatidylinositol-bisphosphatase
-
-
-
-
Phosphoinositide 5-phosphatase
phosphoinositide phosphatase
PI(4,5)P2 5-phosphatase A
-
-
PI(4,5)P2-5'-phosphatase
-
PIB5PA
-
-
PIP2 5-phosphatase
-
-
PIP2 phosphatase
-
-
-
-
PIP3 5-phosphatase
-
-
PtdIns(4,5)P2 5-phosphatase
-
-
-
-
PtdIns(4,5)P2 phosphatase
-
-
PtdIns(4;5)P2 5-phosphatase
-
-
PtdInsP3 5-phosphatase
-
-
rapamycin-inducible PI(4,5)P2 5-phosphatase
-
-
SH2 domain containing inositol 5-phosphatase 2
-
-
SH2-containing inositol polyphosphate 5-phosphatase 2
-
-
SJ-1
-
-
SJ1-145
-
-
SJ1-170
-
-
skeletal muscle and kidney enriched inositol phosphatase
-
-
skeletal muscle- and kidney-enriched inositol polyphosphate phosphatase
-
-
Src homology 2 domain containing inositol polyphosphate 5-phosphatase 2
-
-
Src homology 2-containing inositol 5-phosphatase 1
-
-
Synaptojanin
-
-
-
-
synaptojanin 1
-
-
synaptojanin-1
-
-
synaptojanin1
-
-
synaptojanin2
-
-
synj1
-
-
triphosphoinositide phosphatase
-
-
-
-
triphosphoinositide phosphomonoesterase
-
-
-
-
type II diacylglycerol kinase eta
-
-
type II phosphoinositide 5-phosphatase
-
-
type IV phosphoinositide 5-phoshatase
-
-
voltage-sensitive phosphoinositide phosphatase Ci-VSP
-
additional information
-
cf. EC 3.1.3.56, inositol polyphosphate 5-phosphatase
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
hydrolysis of phosphoric ester
-
-
-
-
PATHWAY SOURCE
PATHWAYS
-
-
SYSTEMATIC NAME
IUBMB Comments
phosphatidyl-myo-inositol-4,5-bisphosphate 4-phosphohydrolase
These enzymes can also remove the 5-phosphate from Ins(1,4,5)P3 and/or Ins(1,3,4,5)P4. They are a diverse family of enzymes, with differing abilities to catalyse two or more of the four reactions listed. They are thought to use inositol lipids rather than inositol phosphates as substrates in vivo. All of them can use either or both of PtdIns(4,5)P2 and PtdIns(3,4,5)P3 as substrates; this is the main property that distinguishes them from EC 3.1.3.56, inositol-polyphosphate 5-phosphatase.
CAS REGISTRY NUMBER
COMMENTARY hide
9036-01-5
-
SUBSTRATE
PRODUCT                       
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate
show the reaction diagram
-
-
-
?
1-phosphatidyl-1D-myo-inositol 3,4,5-triphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
show the reaction diagram
-
-
-
-
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
show the reaction diagram
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate
show the reaction diagram
1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O
1D-myo-inositol 1,3,4-trisphosphate + phosphate
show the reaction diagram
1D-myo-inositol 1,3,4,5-tetrasphosphate + H2O
1D-myo-inositol 1,3,4-trisphosphate + phosphate
show the reaction diagram
-
-
-
-
?
1D-myo-inositol 1,4,5-trisphosphate + H2O
1D-myo-inositol 1,4-bisphosphate + phosphate
show the reaction diagram
-
-
-
-
?
7-nitrobenz-2-oxa-1,3-diazole 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O
7-nitrobenz-2-oxa-1,3-diazole 1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate
show the reaction diagram
-
fluorescence-labeled substrate
-
-
?
D(+)-sn-1,2-di-O-hexadecanoylglyceryl 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
D(+)-sn-1,2-di-O-hexadecanoylglyceryl 1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
show the reaction diagram
-
3-O-phospho-linked
-
-
?
D(+)-sn-1,2-di-O-hexadecanoylglyceryl 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O
D(+)-sn-1,2-di-O-hexadecanoylglyceryl 1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate
show the reaction diagram
-
3-O-phospho-linked, best substrate for synaptojanin2
-
-
?
D-myo-phosphatidylinositol 3,4,5-trisphosphate
D-myo-phosphatidylinositol 3,4-bisphosphate + phosphate
show the reaction diagram
D-myo-phosphatidylinositol 4,5-bisphosphate
D-myo-phosphatidylinositol 4-phosphate + phosphate
show the reaction diagram
-
-
-
-
?
inositol 1,3,4,5-tetrakisphosphate + H2O
inositol 1,3,4-trisphosphate + phosphate
show the reaction diagram
myo-inositol 1,4,5-trisphosphate + H2O
inositol 1,4-diphosphate + phosphate
show the reaction diagram
myo-inositol 3,4,5-trisphosphate + H2O
?
show the reaction diagram
-
-
-
-
?
phosphatidyl-myo-inositol 4,5-bisphosphate + H2O
phosphatidylinositol 4-phosphate + phosphate
show the reaction diagram
phosphatidylinositol 4,5-bisphosphate + H2O
phosphatidylinositol 4-phosphate + phosphate
show the reaction diagram
-
-
-
-
?
additional information
?
-
NATURAL SUBSTRATE
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate
show the reaction diagram
-
-
-
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
show the reaction diagram
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate
show the reaction diagram
additional information
?
-
METALS and IONS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
Mg2+
contains Mg2+
additional information
-
the enzyme reduces the Ca2+ flux in the cell
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
3-benzyl-oxybenzene 1,2,4-trisphosphate
-
-
3-hydroxybenzene 1,2,4-trisphosphate
-
-
4-amino-5-(4-chlorophenyl)-7(t-butyl)pyrazolo(3,4-d)pyrimidine
-
inhibits translocation of SHIP1 to the plasma membrane and tyrsine phosphorylation
ammonyx LO
-
-
benzene 1,2,3,4-tetrakisphosphate
-
-
benzene 1,2,3,5-tetrakisphosphate
-
-
benzene 1,2,3-trisphosphate
benzene 1,2,4,5-tetrakisphosphate
benzene 1,2,4-trisphosphate
-
-
benzene 1,3,5-trisphosphate
-
-
biphenyl 2,3',4,5',6-pentakisphosphate
-
-
Ca2+
-
competitive with Mg2+ in presence of optimal concentrations of Mg2+
hemoglobin
-
at concentrations higher than 1% W/v
-
neomycin
-
inhibits only in absence of Triton X-100
ACTIVATING COMPOUND
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
phosphatidylcholine
-
vesicles of phosphatidylcholine only stimulate SHIP2 activity by 2fold. This effect is specific for di-C8 and di-C16 fatty acids of D-myo-phosphatidylinositol 3,4,5-trisphosphate as substrate
phosphatidylserine
-
vesicles of phosphatidylserine (PtdSer) greatly stimulate SHIP2. This effect is specific for di-C8 and di-C16 fatty acids of D-myo-phosphatidylinositol 3,4,5-trisphosphate as substrate
potassium bisperoxo (1,10-phenanthroline) oxovanadate (V)
-
protein phosphatase inhibitor bpV(phen), a cell permeable derivative, enhances the activity of PtdIns3P3 5-phosphatase, particularly SHIP2
Sodium vanadate
-
protein phosphatase inhibitor enhances the activity of PtdIns3P3 5-phosphatase, particularly SHIP2
additional information
-
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.028
Inositol 1,3,4,5-tetrakisphosphate
-
-
0.123
Inositol 1,4,5-trisphosphate
-
-
0.25 - 0.27
phosphatidyl-myo-inositol 4,5-bisphosphate
IC50 VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.068
3-benzyl-oxybenzene 1,2,4-trisphosphate
Homo sapiens
-
-
0.021
3-hydroxybenzene 1,2,4-trisphosphate
Homo sapiens
-
-
0.098
benzene 1,2,3,4-tetrakisphosphate
Homo sapiens
-
-
0.078
benzene 1,2,3,5-tetrakisphosphate
Homo sapiens
-
-
0.0335 - 0.086
benzene 1,2,3-trisphosphate
0.004 - 0.0063
benzene 1,2,4,5-tetrakisphosphate
0.014
benzene 1,2,4-trisphosphate
Homo sapiens
-
-
0.016
benzene 1,3,5-trisphosphate
Homo sapiens
-
-
0.001
biphenyl 2,3',4,5',6-pentakisphosphate
Homo sapiens
-
-
SPECIFIC ACTIVITY [µmol/min/mg]
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
0.765
-
-
additional information
-
the adaptor protein APS, which specifically interacts with SHIP2, increases the PtdIns(3,4,5)P3 5-phosphatase activity of SHIP2 (76.7% at 3 microM APS and by 111.3% at 6 microM APS)
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
6.8 - 8
-
-
TEMPERATURE OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
30
-
assay at
TEMPERATURE RANGE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
additional information
-
activity declines sharply at temperatures above 37°C
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
SOURCE
-
lowest expression
Manually annotated by BRENDA team
-
highest expression
Manually annotated by BRENDA team
additional information
-
ubiquitously expressed
Manually annotated by BRENDA team
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY hide
GeneOntology No.
LITERATURE
SOURCE
both isoforms a and b predominantly localize to the perinuclear region
-
Manually annotated by BRENDA team
-
SKIP localizes to the ER in HuH-7 cells
Manually annotated by BRENDA team
-
enzyme is associated with the lysosomal membrane
Manually annotated by BRENDA team
-
in HuH-7 cells overexpressing SKIP and infected with hepatitis B virus (HBV), SKIP localizes to nucleus in addition to endoplasmic reticulum and suppresses HBV gene expression and replication. SKIP loses its nuclear localization and suppressive effect during replication of a core-negative HBV mutant
Manually annotated by BRENDA team
-
OCRL1 accumulates on Legionella-containing vacuoles in wild-type Legionella pneumophilia infected Dictyostelium discoideum
Manually annotated by BRENDA team
additional information
OCRL1a is significantly more abundant in the cytoplasmic puncta, and there is less diffuse cytosolic staining compared to isoform b in NRK- and HeLa cells
-
Manually annotated by BRENDA team
GENERAL INFORMATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
malfunction
metabolism
-
the enzyme negatively regulates myogenesis through inhibition of insulin-like growth factor-II production and attenuation of the insulin-like growth factor-II-Akt-mTOR signaling pathway
physiological function
additional information
-
GTP-bound, active Rab35 directly interacts with OCRL and controls its localization at the intercellular bridge
UNIPROT
ENTRY NAME
ORGANISM
NO. OF AA
NO. OF TRANSM. HELICES
MOLECULAR WEIGHT[Da]
SOURCE
SEQUENCE
LOCALIZATION PREDICTION?
OCRL_HUMAN
901
0
104205
Swiss-Prot
other Location (Reliability: 1)
MOLECULAR WEIGHT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
100000
-
x * 100000, SDS-PAGE
104000
-
gel filtration
145000
-
-
170000
-
-
SUBUNIT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
POSTTRANSLATIONAL MODIFICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
phosphoprotein
CRYSTALLIZATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
sitting drop vapor diffusion method
in complex with biphenyl 3,3',4,4',5,5'-hexakisphosphate, to 2.89 A resolution. One inhibitor pole locates in the phospholipid headgroup binding site and the second solvent-exposed ring binds to the His-Tag of another INPP5B molecule, while a molecule of inorganic phosphate is also present in the active site. In complex with benzene 1,2,4,5-tetrakisphosphate, to 2.9 A resolution. Conserved residues among the 5-phosphatase family mediate interactions with the inhibitors similar to those with the polar groups present in positions 1, 4, 5, and 6 on the inositol ring of the substrate. 5-Phosphatase specificity most likely resides in the variable zone located close to the 2- and 3-positions of the inositol ring
sitting drop vapor diffusion method
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
DELTA73-77
deletion of this LIDIA sequence motif within the N-terminal region of OCRL1 reveals that this sequence motif functions as a second clathrin binding domain in both isoforms
DELTAPIP2
expression of OCRL1 isoform a, but not isoform b, lacking the 5-phosphatase domain impairs transferrin endocytosis
G664D
G664D mutation shows little effect on binding to clathrin, alpha-adaptin, Rac1 or APPL1, while binding to Rabs 5 and 6 is almost completely abolished. The effects of G664D mutation are the same for both OCRL1 isoforms
C383S
-
mutant with an almost entirely eliminated 3-phosphatase and 4-phosphatase activity, but a maintained 5-phosphatase activity also fails to rescue the endocytic defects in synj1-/- neurons
C392S
site-directed mutagenesis, inactivating mutation in the conserved CX5R(T/S) motif of the Sac domain
C641A
site-directed mutagenesis, the mutation removes the prenylation site of the enzyme
C910A
mutation of the C-terminal cysteine (C910A), which abolishes prenylation of INPP5B does not affect cellular targeting of INPP5B
D192A
-
to assess the role of catalytic activity of SKIP on its suppressive effect, a phosphatase-negative mutant D192A is generated: 5-phosphatase activity is not required for the suppressive effect
D193/E195A
-
binding activity is much lower compared to wild-type fragment consisting of amino acids 124-314. Binding activity for active RhoA is dramatically reduced compared to wild-type
D223/K224A
-
binding activity is much lower compared to wild-type fragment consisting of amino acids 124-314
D524A
mutation of the aspartic acid within the conserved sequence PAWCDRIL in the 5-phosphatase domain which renders INPP5B catalytically inactive, has no effect on the targeting of INPP5B to the Golgi apparatus, ERGIC or endosomes
D556A
site-directed mutagenesis, inactivating point mutation of the conserved DRVL motif of INPP5E
D730A
-
mutant with a deficient 5-phosphatase activity fails to rescue the endocytic defects in synj1-/- neurons
DELTA1-885/1186-1258
-
the effects of SHIP2 on c-Jun NH2-terminal kinase (JNK) activity and JIP1 (JNK-interacting protein 1) tyrosine phosphorylation are independent of the SHIP2 phosphoinositide 5-phosphatase activity, as similar results are obtained when using a SHIP2 catalytic inactive mutant instead of wild-type SHIP2
DELTA237-893
-
the N-terminal domain of OCRL1 is localized throughout the host cytoplasm and it binds Legionella pneumophila LpnE, a Sel1-like repeat protein involved in Legionella-containing vacuoles formation, which localizes to Legionella-containing vacuoles and selectively binds PtdIns(3)P
P105E
-
Glu in SHIP1 SH2 domain, faster association kinetics for binding to immobilized peptide VApYSYL
P686A/D690A/R691A
-
catalytically inactive dominant-negative mutant inhibits proliferation of preadipocytes more potently than wild-type SHIP2. Phospho-Akt, phospho-ERK1/2, and PDGF receptor (PDGFR) levels are reduced in mutant-expressing preadipocytes. The inhibition of PDGF-activated mitogenic pathways by SHIP2 mutant is consistent with a decrease in PDGFR phosphorylation caused by a drop in receptor levels in SHIP2 mutant-expressing cells. SHIP2 mutant promotes ubiquitination of the PDGFR and its degradation via the lysosomal pathway independently of the association between the E3 ubiquitin ligase c-Cbl and PDGFR
P88S
-
Ser in SHIP1 SH2 domain, faster association kinetics for binding to immobilized peptide VApYSYL
additional information
TEMPERATURE STABILITY
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
4
-
half-life: about 1 day
GENERAL STABILITY
ORGANISM
UNIPROT
LITERATURE
inactivated by freezing
-
Triton X-100 stabilizes
-
STORAGE STABILITY
ORGANISM
UNIPROT
LITERATURE
4°C, half-life: about 1 day
-
PURIFICATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
immobilized metal ion affinity chromatography (Co2+), gel filtration
-
Ni2+-colums
-
partial
-
recombinant GST-tagged catalytic domains of synaptojanin2 and OCRL from Escherichia coli strain DH5alpha by glutathione affinity chromatography
-
CLONED (Commentary)
ORGANISM
UNIPROT
LITERATURE
expressed in Saccharomyces cerevisiae and in NRK- and HeLa cells
DNA and amino acid sequence detremination and analysis, expression of GFP-tagged synaptojanin-1 in CHO cells
-
expressed as a HIS-tagged fusion protein in 3T3-L1 adipocytes and in CHO-IR cells (Chinese hamster ovary cells stably transfected with the insulin receptor)
-
expressed in COS-7 cells and in Saccharomyces cerevisiae
-
expressed in Dictyostelium discoideum
-
expressed in Escherichia coli as a GST-fusion protein and as a Flag-tagged fusion protein in human hepatoma HuH-7 cells
-
expressed in Escherichia coli as a GST-tagged protein
-
expressed in Escherichia coli BL21(DE3) cells
-
expressed in HEK293 cells
-
expressed in murine 3T3-L1 preadipocytes
-
expression in baculovirus-infected Sf9 cells
-
expression in Escherichia coli
expression of GST-tagged catalytic domains, comprising residues D474-R959 of synaptojanin2 and residues V202-E618 of OCRL, in Escherichia coli strain DH5alpha
-
full-length human INPP5B cDNA is cloned into pEGFP-C3 with an N-terminal FLAG tag for in vivo expression. INPP5B cDNA is cloned into pGBKT7 for yeast two-hybrid experiments and pBAC2 for expression of recombinant protein in insect cells. DNA encoding the N-terminal 229 amino acids of INPP5B is cloned into pET41EK-LIC for expression of GST-tagged protein in Escherichia coli
full-length SJ1-145 is cloned into the peGFP-C1 vector
-
full-length SJ1-170 is cloned into the peGFP-C1 vector
-
SH2 domain
-
SH2 domain, a maltose-binding protein fusion protein and a His-tagged version expressed in Escherichia coli
-
EXPRESSION
ORGANISM
UNIPROT
LITERATURE
enzyme expression, which is markedly elevated during cell differentiation
-
isoform INPP5E is overexpressed in cervical cancer, non-Hodgkin’s lymphoma, and uterine leiomyosarcoma
the enzyme is downregulated in human melanoma
-
APPLICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
molecular biology
OCRL1 exists as two functional pools, one participating in clathrin-mediated trafficking events such as endocytosis, and another that is much less or not involved in this process
medicine
-
examination of patients with Lowe oculocerebrorenal syndrome, MIM 309000, and their families for mutations in enzyme gene
molecular biology
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Matzaris, M.; Jackson, S.P.; Laxminarayan, K.M.; Speed, C.J.; Mitchell, C.A.
Identification and characterization of the phosphatidylinositol-(4,5)-bisphosphate 5-phosphatase in human platelets
J. Biol. Chem.
269
3397-33402
1994
Homo sapiens
Manually annotated by BRENDA team
Mack, S.E.; Palmer, F.B.St.C.
Evidence for a specific phosphatidylinositol 4-phosphate phosphatase in human erythrocyte membranes
J. Lipid Res.
25
75-85
1984
Canis lupus familiaris, Oryctolagus cuniculus, Ovis aries, Homo sapiens, Platyrrhini, Rattus norvegicus
Manually annotated by BRENDA team
Mack, S.E.; Palmer, F.B.St.C.
Soluble and membrane-bound polyphosphoinositide phosphohydrolases in mammalian erythrocytes
Biochem. Cell Biol.
66
199-207
1988
Oryctolagus cuniculus, Ovis aries, Homo sapiens, Rattus norvegicus, Sus scrofa
Manually annotated by BRENDA team
Roach, P.D.; Palmer, F.B.St.C.
Human erythrocyte cytosol phosphatidyl-inositol-bisphosphate phosphatase
Biochim. Biophys. Acta
661
323-333
1981
Homo sapiens
Manually annotated by BRENDA team
Zhang, X.; Jefferson, A.B.; Auethavekiat, V.; Majerus, P.W.
The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase
Proc. Natl. Acad. Sci. USA
92
4853-4856
1995
Homo sapiens
Manually annotated by BRENDA team
Zhang, X.; Hartz, P.A.; Philip, E.; Racusen, L.C.; Majerus, P.W.
Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate
J. Biol. Chem.
273
1574-1582
1998
Homo sapiens
Manually annotated by BRENDA team
Suchy, S.F.; Olivos-Glander, I.; Nussbaum, R.L.
Lowe syndrome, a deficiency of a phosphatidyl-inositol 4,5-bisphosphate 5-phosphatase in the Golgi apparatus
Hum. Mol. Genet.
4
2245-2250
1995
Homo sapiens
Manually annotated by BRENDA team
Roschinger, W.; Muntau, A.C.; Rudolph, G.; Roscher, A.A.; Kammerer, S.
Carrier assessment in families with Lowe oculocerebrorenal syndrome: Novel mutations in the OCRL1 gene and correlation of direct DNA diagnosis with ocular examination
Mol. Genet. Metab.
69
213-222
2000
Homo sapiens
Manually annotated by BRENDA team
Johenning, F.W.; Wenk, M.R.; Uhlen, P.; Degray, B.; Lee, E.; De Camilli, P.; Ehrlich, B.E.
InsP3-mediated intracellular calcium signalling is altered by expression of synaptojanin-1
Biochem. J.
382
687-694
2004
Homo sapiens
Manually annotated by BRENDA team
Schmid, A.C.; Wise, H.M.; Mitchell, C.A.; Nussbaum, R.; Woscholski, R.
Type II phosphoinositide 5-phosphatases have unique sensitivities towards fatty acid composition and head group phosphorylation
FEBS Lett.
576
9-13
2004
Homo sapiens, Mus musculus, Rattus norvegicus
Manually annotated by BRENDA team
Batty, I.H.; van der Kaay, J.; Gray, A.; Telfer, J.F.; Dixon, M.J.; Downes, C.P.
The control of phosphatidylinositol 3,4-bisphosphate concentrations by activation of the Src homology 2 domain containing inositol polyphosphate 5-phosphatase 2, SHIP2
Biochem. J.
407
255-266
2007
Homo sapiens, Mus musculus (Q9JII1)
Manually annotated by BRENDA team
Vaillancourt, M.; Levasseur, S.; Tremblay, M.L.; Marois, L.; Rollet-Labelle, E.; Naccache, P.H.
The Src homology 2-containing inositol 5-phosphatase 1 (SHIP1) is involved in CD32a signaling in human neutrophils
Cell. Signal.
18
2022-2032
2006
Homo sapiens
Manually annotated by BRENDA team
Vandeput, F.; Backers, K.; Villeret, V.; Pesesse, X.; Erneux, C.
The influence of anionic lipids on SHIP2 phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase activity
Cell. Signal.
18
2193-2199
2006
Homo sapiens
Manually annotated by BRENDA team
van Zeijl, L.; Ponsioen, B.; Giepmans, B.N.; Ariaens, A.; Postma, F.R.; Varnai, P.; Balla, T.; Divecha, N.; Jalink, K.; Moolenaar, W.H.
Regulation of connexin43 gap junctional communication by phosphatidylinositol 4,5-bisphosphate
J. Cell Biol.
177
881-891
2007
Homo sapiens
Manually annotated by BRENDA team
Williams, C.; Choudhury, R.; McKenzie, E.; Lowe, M.
Targeting of the type II inositol polyphosphate 5-phosphatase INPP5B to the early secretory pathway
J. Cell Sci.
120
3941-3951
2007
Homo sapiens (P32019)
Manually annotated by BRENDA team
Onnockx, S.; De Schutter, J.; Blockmans, M.; Xie, J.; Jacobs, C.; Vanderwinden, J.M.; Erneux, C.; Pirson, I.
The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners
J. Cell. Physiol.
214
260-272
2008
Homo sapiens
Manually annotated by BRENDA team
Mani, M.; Lee, S.Y.; Lucast, L.; Cremona, O.; Di Paolo, G.; De Camilli, P.; Ryan, T.A.
The dual phosphatase activity of synaptojanin1 is required for both efficient synaptic vesicle endocytosis and reavailability at nerve terminals
Neuron
56
1004-1018
2007
Homo sapiens
Manually annotated by BRENDA team
Perera, R.M.; Zoncu, R.; Lucast, L.; De Camilli, P.; Toomre, D.
Two synaptojanin 1 isoforms are recruited to clathrin-coated pits at different stages
Proc. Natl. Acad. Sci. USA
103
19332-19337
2006
Homo sapiens
Manually annotated by BRENDA team
Hung, C.S.; Lin, Y.L.; Wu, C.I.; Huang, C.J.; Ting, L.P.
Suppression of hepatitis B viral gene expression by phosphoinositide 5-phosphatase SKIP
Cell. Microbiol.
11
37-50
2009
Homo sapiens
Manually annotated by BRENDA team
Weber, S.S.; Ragaz, C.; Hilbi, H.
The inositol polyphosphate 5-phosphatase OCRL1 restricts intracellular growth of Legionella, localizes to the replicative vacuole and binds to the bacterial effector LpnE
Cell. Microbiol.
11
442-460
2008
Dictyostelium discoideum, Homo sapiens, Mus musculus
Manually annotated by BRENDA team
Xie, J.; Onnockx, S.; Vandenbroere, I.; Degraef, C.; Erneux, C.; Pirson, I.
The docking properties of SHIP2 influence both JIP1 tyrosine phosphorylation and JNK activity
Cell. Signal.
20
1432-1441
2008
Homo sapiens
Manually annotated by BRENDA team
Mills, S.J.; Vandeput, F.; Trusselle, M.N.; Safrany, S.T.; Erneux, C.; Potter, B.V.
Benzene polyphosphates as tools for cell signalling: inhibition of inositol 1,4,5-trisphosphate 5-phosphatase and interaction with the pH domain of protein kinase Balpha
ChemBioChem
9
1757-1766
2008
Homo sapiens
Manually annotated by BRENDA team
Xie, J.; Vandenbroere, I.; Pirson, I.
SHIP2 associates with intersectin and recruits it to the plasma membrane in response to EGF
FEBS Lett.
582
3011-3017
2008
Homo sapiens
Manually annotated by BRENDA team
Thyagarajan, B.; Lukacs, V.; Rohacs, T.
Hydrolysis of phosphatidylinositol 4,5-bisphosphate mediates calcium-induced inactivation of TRPV6 channels
J. Biol. Chem.
283
14980-14987
2008
Homo sapiens
Manually annotated by BRENDA team
Choudhury, R.; Noakes, C.J.; McKenzie, E.; Kox, C.; Lowe, M.
Differential clathrin binding and subcellular localization of OCRL1 splice isoforms
J. Biol. Chem.
284
9965-9973
2009
Homo sapiens (Q01968)
Manually annotated by BRENDA team
Artemenko, Y.; Gagnon, A.; Sorisky, A.
Catalytically inactive SHIP2 inhibits proliferation by attenuating PDGF signaling in 3T3-L1 preadipocytes
J. Cell. Physiol.
218
228-236
2009
Homo sapiens
Manually annotated by BRENDA team
Zhang, Y.; Wavreille, A.S.; Kunys, A.R.; Pei, D.
The SH2 domains of inositol polyphosphate 5-phosphatases SHIP1 and SHIP2 have similar ligand specificity but different binding kinetics
Biochemistry
48
11075-11083
2009
Homo sapiens
Manually annotated by BRENDA team
Cui, S.; Guerriero, C.; Szalinski, C.; Kinlough, C.; Hughey, R.; Weisz, O.
OCRL1 function in renal epithelial membrane traffic
Am. J. Physiol. Renal Physiol.
298
F335-F345
2010
Canis lupus familiaris, Homo sapiens
Manually annotated by BRENDA team
Lindner, M.; Leitner, M.G.; Halaszovich, C.R.; Hammond, G.R.; Oliver, D.
Probing the regulation of TASK potassium channels by PI(4,5)P2 with switchable phosphoinositide phosphatases
J. Physiol.
589
3149-3162
2011
Homo sapiens (Q9NRR6)
Manually annotated by BRENDA team
Dambournet, D.; MacHicoane, M.; Chesneau, L.; Sachse, M.; Rocancourt, M.; El Marjou, A.; Formstecher, E.; Salomon, R.; Goud, B.; Echard, A.
Rab35 GTPase and OCRL phosphatase remodel lipids and F-actin for successful cytokinesis
Nat. Cell Biol.
13
981-988
2011
Homo sapiens
Manually annotated by BRENDA team
Miyazawa, K.
Phosphoinositide 5-phosphatases: How do they affect tumourigenesis?
J. Biochem.
153
1-3
2013
Homo sapiens (Q9NRR6)
Manually annotated by BRENDA team
Ijuin, T.; Takenawa, T.
Role of phosphatidylinositol 3,4,5-trisphosphate (PIP3) 5-phosphatase skeletal muscle- and kidney-enriched inositol polyphosphate phosphatase (SKIP) in myoblast differentiation
J. Biol. Chem.
287
31330-31341
2012
Homo sapiens, Mus musculus
Manually annotated by BRENDA team
Ye, Y.; Jin, L.; Wilmott, J.S.; Hu, W.L.; Yosufi, B.; Thorne, R.F.; Liu, T.; Rizos, H.; Yan, X.G.; Dong, L.; Tay, K.H.; Tseng, H.Y.; Guo, S.T.; de Bock, C.E.; Jiang, C.C.; Wang, C.Y.; Wu, M.; Zhang, L.J.; Hersey, P.; Scolyer, R.A.; Zhang, X.D.
PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma
Nat. Commun.
4
1508
2013
Homo sapiens
Manually annotated by BRENDA team
Braun, W.; Schein, C.
Membrane interaction and functional plasticity of inositol polyphosphate 5-phosphatases
Structure
22
664-666
2014
Homo sapiens, Homo sapiens (P32019)
Manually annotated by BRENDA team
Tresaugues, L.; Silvander, C.; Flodin, S.; Welin, M.; Nyman, T.; Graeslund, S.; Hammarstroem, M.; Berglund, H.; Nordlund, P.
Structural basis for phosphoinositide substrate recognition, catalysis, and membrane interactions in human inositol polyphosphate 5-phosphatases
Structure
22
744-755
2014
Homo sapiens (P32019), Homo sapiens (Q01968), Homo sapiens
Manually annotated by BRENDA team
Kato, K.; Yazawa, T.; Taki, K.; Mori, K.; Wang, S.; Nishioka, T.; Hamaguchi, T.; Itoh, T.; Takenawa, T.; Kataoka, C.; Matsuura, Y.; Amano, M.; Murohara, T.; Kaibuchi, K.
The inositol 5-phosphatase SHIP2 is an effector of RhoA and is involved in cell polarity and migration
Mol. Biol. Cell
23
2593-2604
2012
Homo sapiens
Manually annotated by BRENDA team
Mills, S.J.; Silvander, C.; Cozier, G.; Tresaugues, L.; Nordlund, P.; Potter, B.V.
Crystal Structures of type-II inositol polyphosphate 5-phosphatase INPP5B with synthetic inositol polyphosphate surrogates reveal new mechanistic insights for the inositol 5-phosphatase family
Biochemistry
55
1384-1397
2016
Homo sapiens (P32019)
Manually annotated by BRENDA team
Kume, A.; Kawase, K.; Komenoi, S.; Usuki, T.; Takeshita, E.; Sakai, H.; Sakane, F.
The pleckstrin homology domain of diacylglycerol kinase eta strongly and selectively binds to phosphatidylinositol 4,5-bisphosphate
J. Biol. Chem.
291
8150-8161
2016
Homo sapiens
Manually annotated by BRENDA team